Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page

Q1-2020 Dermatology Update

Skip to the end of the Expertise Menu

Q1-2020 Dermatology Update

Although consolidation activity within dermatology had been fairly muted to start the year, the quarter still saw a landmark transaction take place in Sun Capital’s recapitalization of West Dermatology, previously backed by Enhanced Healthcare Partners (EHP). The multistate, Southwest-focused platform more than doubled its clinic count, executing on 22 add-on acquisitions over EHP’s 5.5 year hold period. This transaction marks the eighth dermatology platform that has traded private equity hands since institutional investment began to take place in the sector and is a sign of increasing market maturity.

The obvious and more pressing development to transpire throughout the quarter was the sudden and unforeseen rise of COVID-19 and its crippling impact in the business and medical world. With state-wide shutdowns and CDC guidance prompting furloughs, cancellations, and an overall massive reduction in volume, independent and PE-backed practices alike find themselves trying to navigate through increasing levels of uncertainty.

Government relief packages and CMS’ expansion of telehealth services will prove crucial over the next few months, with potential further stimulus on the horizon. Provident expects significant delays in transaction volume as buyers and sellers both turn to focusing efforts on managing their existing businesses. Operational preparation to ensure patient, provider and staff retention will be key to capturing pent up demand for services when the pandemic subsides.

To print and download the full Dermatology Update report, please click below…

[holo_button icon=”” link=”/wp-content/uploads/2020/04/Q1-2020-Dermatology-Newsletter.pdf” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]

Sources: SEC Filings; Company Press Releases, and Reports; IBISWorld; Capital IQ; PHP Estimates and Research. This document has been compiled with publicly available information. Provident Healthcare Partners, LLC makes no guarantee of its accuracy or completeness. No data or statement should be construed to be a recommendation for the purchase, sale, or retention of any security.